Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension

American Journal of Hypertension
A L SwislockiG M Reaven

Abstract

Plasma glucose and insulin responses to an oral glucose challenge and insulin-stimulated glucose uptake were measured in 47 age-, weight-, and sex-matched lean white men (16 with normal blood pressure, 14 with untreated hypertension, nine treated with a thiazide diuretic only, and eight treated with combined diuretic and beta-adrenergic antagonist drugs). Following a 75-g glucose dose, plasma glucose and insulin were measured for a three-hour period. In separate studies, insulin-stimulated glucose uptake was estimated by measuring the steady-state plasma glucose (SSPG) and insulin (SSPI) concentrations achieved during the last 30 minutes of a 180-minute continuous infusion of somatostatin, insulin, and glucose (insulin suppression test). Under these conditions endogenous insulin secretion was suppressed, and differences in SSPG concentration allowed comparisons of the ability of exogenous insulin to stimulate disposal of an identical glucose load in different individuals. The results indicated that men with untreated hypertension had significantly elevated plasma glucose (P less than .001) and insulin concentrations (P less than .001) after an oral challenge compared to normal volunteers. Mean SSPG concentrations were also high...Continue Reading

Citations

Dec 1, 1992·Cardiovascular Drugs and Therapy·L H Opie
Aug 1, 1992·Postgraduate Medicine·J R Sowers
May 1, 1992·Hypertension·M Epstein, J R Sowers
Oct 1, 1991·Postgraduate Medical Journal·P A RutherfordR Wilkinson
Mar 14, 1991·The New England Journal of Medicine·M F SaadB V Howard
Nov 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·B FalknerJ B Marsh
Jan 1, 1995·Clinical and Experimental Hypertension : CHE·M S MuntzelA L Mark
Sep 1, 1994·Clinical and Experimental Hypertension : CHE·W H SheuM M Fuh
Feb 1, 1994·Cardiovascular Drugs and Therapy·C R Swanepoel
Mar 1, 1993·Hypertension·A M SharmaA Distler
Sep 1, 1996·Blood Pressure·L Berglund, H Lithell
Apr 11, 2000·Current Opinion in Nephrology and Hypertension·V M CampeseR Bigazzi
Feb 28, 2001·Diabetes, Obesity & Metabolism·M J Katovich, A Pachori
May 3, 2002·Journal of Human Hypertension·L X Cubeddu, I S Hoffmann
Jul 1, 2004·Circulation Journal : Official Journal of the Japanese Circulation Society·Kazuo MurakamiJitsuo Higaki
Mar 2, 2006·Biological & Pharmaceutical Bulletin·Kenji SakamotoKunio Ishii
Apr 4, 2006·Journal of the American College of Nutrition·Harry G PreussRichard Anderson
Jun 10, 2006·The American Journal of Clinical Nutrition·Gerald M Reaven
Feb 23, 2008·American Journal of Human Biology : the Official Journal of the Human Biology Council·El Ayachi MohammedBelahsen Rekia
Nov 16, 2007·Blood Pressure Monitoring·Gregory P VyssoulisChristodoulos I Stefanadis
May 26, 2009·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Nicolas W ShammasPeter P Toth
Jul 6, 2014·The Journal of Urology·Prince SinghAndrew D Rule
Mar 22, 2016·JRSM Cardiovascular Disease·Thang S Han, Mike Ej Lean
Mar 1, 1992·Journal of Internal Medicine·I ZavaroniG M Reaven
Oct 21, 1992·International Journal of Cancer. Journal International Du Cancer·P F BruningW J Nooijen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.